DiscoverVJHemOnc PodcastExtramedullary disease in multiple myeloma: biology, management strategies, & the RedirecTT-1 trial
Extramedullary disease in multiple myeloma: biology, management strategies, & the RedirecTT-1 trial

Extramedullary disease in multiple myeloma: biology, management strategies, & the RedirecTT-1 trial

Update: 2025-08-08
Share

Description

In this episode of the VJHemOnc Podcast, we dive into one of the more aggressive and challenging manifestations of multiple myeloma, extramedullary disease (EMD). We are joined by experts Meral Beksac, MD, Istinye University Ankara Liv Hospital, Ankara, Turkey, Mehmet Samur, PhD, Dana-Farber Cancer Institute, Boston, MA, Saurabh Zanwar, MD, MBBS, Mayo Clinic, Rochester, MN, and Shaji Kumar, MD, Mayo Clinic, Rochester, MN. They discuss the latest insights on how EMD presents, how it’s managed, and what we’re learning about its complex biology. Plus, we’ll explore emerging treatment strategies and clinical trials, including the RedirecTT-1 trial (NCT04586426).

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Extramedullary disease in multiple myeloma: biology, management strategies, & the RedirecTT-1 trial

Extramedullary disease in multiple myeloma: biology, management strategies, & the RedirecTT-1 trial

VJHemOnc